Poly Medicure Limited
Symbol: POLYMED.NS
NSE
1585.05
INRMarktpreis heute
61.3484
P/E-Verhältnis
311.8541
PEG-Verhältnis
152.12B
MRK Kapital
- 0.00%
DIV Rendite
Poly Medicure Limited (POLYMED-NS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3090.3 | 3516.7 | 3742.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 3019.7 | 3439.1 | 3693.1 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2357.3 | 2403.3 | 1884.5 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 2086.5 | 1683.6 | 1264.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 535.9 | 230.7 | 165.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 8070.1 | 7834.4 | 7057.8 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 6623.8 | 4769.7 | 3910.2 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 285.8 | 285.8 | 285.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 215.5 | 220.7 | 228.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 501.3 | 506.6 | 514.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 89.7 | 204.2 | 508.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 109.1 | 453.6 | 165.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 378.1 | 0 | 81.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7702 | 5934 | 5179.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 923.1 | 890.4 | 645.2 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1301.7 | 882 | 721.8 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 8.4 | 0 | 7.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 188.5 | 385.1 | 652.4 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 27.4 | 35.3 | 43.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 328.5 | 230.7 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 422.8 | 626.8 | 867.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 25.8 | 14.3 | 32.9 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3355.8 | 2893.5 | 2581.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 479.7 | 479.5 | 479.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 5277.5 | 3990.4 | 3041.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2730.4 | 2486.2 | 2216.2 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3928.7 | 3918.7 | 3918.5 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 189.7 | 286 | 578.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 1490.2 | 1267.1 | 1374.3 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 1419.5 | 1189.5 | 1324.7 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -602 | -623.2 | -530.3 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 19.3 | 9.3 | 6.5 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -499.6 | -633.9 | -611.9 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -288 | -507.4 | -332.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -402.9 | -418.8 | -143.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 37.7 | 247 | 0.6 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 153.6 | 45.2 | -136.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 44 | -9.5 | 47.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.5 | 15.1 | 6.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -579.1 | -660.6 | -3444.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 577.6 | 645.4 | -6.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 602.6 | 702.5 | 39.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1790.2 | -853.3 | -4355.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -209.9 | -62.8 | -664.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.5 | 1 | 4000 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -209.9 | 62.8 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -239.7 | -239.2 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 531 | -115.2 | -166 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -125.1 | -353.4 | 3169.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -7 | 28 | 1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 70.6 | 77.6 | 49.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 77.6 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1908.3 | 1234.7 | 1187.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -484.5 | -321.1 | 236 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 11152.3 | 9168.9 | 7750.4 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4058.8 | 4332.3 | 3364.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 7093.6 | 4836.6 | 4385.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 5011.4 | 3195 | 2683.1 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 9070.1 | 7527.3 | 6047.8 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 59.7 | 22.9 | 33.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | 2087.5 | 1596.2 | 1668.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 582.1 | 487.4 | 441.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | 1792.8 | 1465.1 | 1358.7 |
Häufig gestellte Frage
Wie hoch ist die Poly Medicure Limited (POLYMED.NS) Gesamtvermögen?
Poly Medicure Limited (POLYMED.NS) Gesamtvermögen ist 15772092000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.650.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 10.150.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.191.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.248.
Was ist der Poly Medicure Limited (POLYMED.NS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 1792825000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 1490168000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 5011373000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.